Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1265716.RAdaA3VQdHALBt_ViPFW64qAQW043pYq3etZQji9VqpoI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1265716.RAdaA3VQdHALBt_ViPFW64qAQW043pYq3etZQji9VqpoI130_assertion type Assertion NP1265716.RAdaA3VQdHALBt_ViPFW64qAQW043pYq3etZQji9VqpoI130_head.
- NP1265716.RAdaA3VQdHALBt_ViPFW64qAQW043pYq3etZQji9VqpoI130_assertion description "[Further investigation demonstrated that a high miR-21 expression can predict poor overall survival (OS) (HR = 2.57, 95% CI: 1.37-4.81, P = 0.003) and shortened disease-free/recurrence-free survival (DFS/RFS) (HR = 1.45, 95% CI: 1.16-1.82, P = 0.001) in breast cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1265716.RAdaA3VQdHALBt_ViPFW64qAQW043pYq3etZQji9VqpoI130_provenance.
- NP1265716.RAdaA3VQdHALBt_ViPFW64qAQW043pYq3etZQji9VqpoI130_assertion evidence source_evidence_literature NP1265716.RAdaA3VQdHALBt_ViPFW64qAQW043pYq3etZQji9VqpoI130_provenance.
- NP1265716.RAdaA3VQdHALBt_ViPFW64qAQW043pYq3etZQji9VqpoI130_assertion SIO_000772 25706383 NP1265716.RAdaA3VQdHALBt_ViPFW64qAQW043pYq3etZQji9VqpoI130_provenance.
- NP1265716.RAdaA3VQdHALBt_ViPFW64qAQW043pYq3etZQji9VqpoI130_assertion wasDerivedFrom befree-2016 NP1265716.RAdaA3VQdHALBt_ViPFW64qAQW043pYq3etZQji9VqpoI130_provenance.
- NP1265716.RAdaA3VQdHALBt_ViPFW64qAQW043pYq3etZQji9VqpoI130_assertion wasGeneratedBy ECO_0000203 NP1265716.RAdaA3VQdHALBt_ViPFW64qAQW043pYq3etZQji9VqpoI130_provenance.